Unknown

Dataset Information

0

The aspirin metabolite salicylate inhibits lysine acetyltransferases and MUC1 induced epithelial to mesenchymal transition.


ABSTRACT: MUC1 is a transmembrane mucin that can promote cancer progression, and its upregulation correlates with a worse prognosis in colon cancer. We examined the effects of overexpression of MUC1 in colon cancer cells, finding that it induced epithelial to mesenchymal transition (EMT), including enhanced migration and invasion, and increased Akt phosphorylation. When the clones were treated with the aspirin metabolite salicylate, Akt phosphorylation was decreased and EMT inhibited. As the salicylate motif is necessary for the activity of the lysine acetyltransferase (KAT) inhibitor anacardic acid, we hypothesized these effects were associated with the inhibition of KAT activity. This was supported by anacardic acid treatment producing the same effect on EMT. In vitro KAT assays confirmed that salicylate directly inhibited PCAF/Kat2b, Tip60/Kat5 and hMOF/Kat8, and this inhibition was likely involved in the reversal of EMT in the metastatic prostate cancer cell line PC-3. Salicylate treatment also inhibited EMT induced by cytokines, illustrating the general effect it had on this process. The inhibition of both EMT and KATs by salicylate presents a little explored activity that could explain some of the anti-cancer effects of aspirin.

SUBMITTER: Fernandez HR 

PROVIDER: S-EPMC5514058 | BioStudies | 2017-01-01

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC3939868 | BioStudies
2020-01-01 | S-EPMC7590440 | BioStudies
1000-01-01 | S-EPMC6035838 | BioStudies
2012-01-01 | S-EPMC3463216 | BioStudies
2017-01-01 | S-EPMC5292092 | BioStudies
2014-01-01 | S-EPMC3783575 | BioStudies
2019-01-01 | S-EPMC6774902 | BioStudies
2015-01-01 | S-EPMC4530107 | BioStudies
2017-01-01 | S-EPMC5548633 | BioStudies
2016-01-01 | S-EPMC5023457 | BioStudies